These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9573427)

  • 1. Substance abuse treatment for pregnant women: a window of opportunity?
    Daley M; Argeriou M; McCarty D
    Addict Behav; 1998; 23(2):239-49. PubMed ID: 9573427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The costs of crime and the benefits of substance abuse treatment for pregnant women.
    Daley M; Argeriou M; McCarty D; Callahan JJ; Shepard DS; Williams CN
    J Subst Abuse Treat; 2000 Dec; 19(4):445-58. PubMed ID: 11166509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers to receiving substance abuse treatment among rural pregnant women in Kentucky.
    Jackson A; Shannon L
    Matern Child Health J; 2012 Dec; 16(9):1762-70. PubMed ID: 22139045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance use in pregnancy.
    Wong S; Ordean A; Kahan M; ; ; ; ;
    J Obstet Gynaecol Can; 2011 Apr; 33(4):367-384. PubMed ID: 21501542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stay in residential facilities and mental health care as predictors of readmission for patients with substance use disorders.
    Moos RH; Moos BS
    Psychiatr Serv; 1995 Jan; 46(1):66-72. PubMed ID: 7895125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of substance abuse during pregnancy and infant outcome.
    Little BB; Snell LM; Van Beveren TT; Crowell RB; Trayler S; Johnston WL
    Am J Perinatol; 2003 Jul; 20(5):255-62. PubMed ID: 13680509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics associated with pregnant women's utilization of substance abuse treatment services.
    Messer K; Clark KA; Martin SL
    Am J Drug Alcohol Abuse; 1996 Aug; 22(3):403-22. PubMed ID: 8841688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managed care and the quality of substance abuse treatment.
    Shepard DS; Daley M; Ritter GA; Hodgkin D; Beinecke RH
    J Ment Health Policy Econ; 2002 Dec; 5(4):163-74. PubMed ID: 14578550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in successful treatment completion among pregnant and non-pregnant American women.
    Sahker E; McCabe JE; Arndt S
    Arch Womens Ment Health; 2016 Feb; 19(1):79-86. PubMed ID: 25824855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of the pregnant substance abusing woman.
    Sheehan M; Sheehan MG
    Clin Obstet Gynecol; 2013 Mar; 56(1):97-106. PubMed ID: 23337845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women in residential drug treatment: differences by program type and pregnancy.
    Grella CE
    J Health Care Poor Underserved; 1999 May; 10(2):216-29. PubMed ID: 10224827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of cocaine addiction during pregnancy.
    Farkas KJ; Parran TV
    Clin Perinatol; 1993 Mar; 20(1):29-45. PubMed ID: 8458170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug treatment, health, and social service utilization by substance abusing women from a community-based sample.
    Hansen H; Alegría M; Cabán CA; Peña M; Lai S; Shrout P
    Med Care; 2004 Nov; 42(11):1117-24. PubMed ID: 15586839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adolescent Pregnancy Guidelines.
    Fleming N; O'Driscoll T; Becker G; Spitzer RF;
    J Obstet Gynaecol Can; 2015 Aug; 37(8):740-756. PubMed ID: 26474231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A search for strategies to engage women in substance abuse treatment.
    Comfort M; Loverro J; Kaltenbach K
    Soc Work Health Care; 2000; 31(4):59-70. PubMed ID: 11140343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors associated with dropout and readmission among First Nations individuals admitted to an inpatient alcohol and drug detoxification program.
    Callaghan RC
    CMAJ; 2003 Jul; 169(1):23-7. PubMed ID: 12847035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of substance abuse treatment modality on birth weight and health care expenditures.
    Daley M; Argeriou M; McCarty D; Callahan JJ; Shepard DS; Williams CN
    J Psychoactive Drugs; 2001; 33(1):57-66. PubMed ID: 11333002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV women's health: a study of gynecological healthcare service utilization in a U.S. urban clinic population.
    Tello MA; Yeh HC; Keller JM; Beach MC; Anderson JR; Moore RD
    J Womens Health (Larchmt); 2008 Dec; 17(10):1609-14. PubMed ID: 19049355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal Substance Use Disorders and Infant Outcomes in the First Year of Life among Massachusetts Singletons, 2003-2010.
    Hwang SS; Diop H; Liu CL; Yu Q; Babakhanlou-Chase H; Cui X; Kotelchuck M
    J Pediatr; 2017 Dec; 191():69-75. PubMed ID: 29050752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of waiting time on substance abuse treatment completion in pregnant women.
    Albrecht J; Lindsay B; Terplan M
    J Subst Abuse Treat; 2011 Jul; 41(1):71-7. PubMed ID: 21353440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.